Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 298-995-1 | CAS number: 93841-25-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 3-(2-hydroxyethyl)-p-phenylenediammonium sulphate
- EC Number:
- 298-995-1
- EC Name:
- 3-(2-hydroxyethyl)-p-phenylenediammonium sulphate
- Cas Number:
- 93841-25-9
- Molecular formula:
- C8H12N2O.H2O4S
- IUPAC Name:
- 2-(2,5-Diaminophenyl)ethanol sulfate (1:1)
Constituent 1
- Specific details on test material used for the study:
- Trade name : Betoxol
Purity : >98%
Test animals
- Species:
- mouse
- Strain:
- other: Him : OFl
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Number in the preliminary study : Four females
Number in the main study : Twenty five males and twenty five females
Age : Approx 8 weeks at the time of administration
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: Distilled water
- Doses:
- 20, 36, 63, 112, 200 mg/kg bw
- No. of animals per sex per dose:
- Ten (5 males and 5 females) per dose group
- Control animals:
- yes
- Details on study design:
- Justification for the selection of the doses : In a preliminary test 4/4 animals (2 per dose) died at doses of 200 and 2000 mg/kg bw. Based on this information, 200 mg/kg bw was chosen as the highest dose. The lowest dose was 10% of the highest dose. The other doses were interpolated. Behaviour, reactions and physical signs of the animals were observed 1, 10, 30 min, 1, 2, 4 and 6 hours after administration and then at least once a day for 2 weeks. Findings were recorded. Body weight was determined before administration, 7 days and 14 days post administration. All animals that died were dissected and examined macroscopically in an attempt to identify the target organs. All surviving animals were sacrificed by CO2 14 days post administration and examined macroscopically.
- Statistics:
- LD50 and 95 CL were calculated according to Thompson (Bact. Rev. 11 (1947)).
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 80 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 71 - <= 89
- Mortality:
- 1/10 animals in group 3 (63 mg/kg bw), 10/10 in group 4 (112 mg/kg bw) and 10/10 in group 5 (200 mg/kg bw) died early. Death occurred within 2 hours (males) and 1 hour (females) after test substance administration in the highest dose group 5 (200 mg/kg bw), within 6 hours (males) and 4 days (females) in group 4 (112 mg/kg bw), within 4 hours (one male) in group 3 (63 mg/kg bw).
- Clinical signs:
- other: Some unspecific signs of general malaise, decreased motor activities, ruffled fur, closed eyes, hunched posture, decreased muscular tension, unconsciousness were noted during the observation time in all animals. In some animals ataxia, dyspnoea or minor c
- Gross pathology:
- At post mortem examination of the early deaths alterations of the small intestine, discoloured liver, small spleen and lung oedema were observed. Post mortem findings indicated an irritative effect to small intestine which was deemed to be the cause of death and additionally a hepatotoxic effect. All surviving animals and seven of the early died animals were normal at post mortem examination. In most of the other early died animals an abundant yellow aqueous content in the small intestine was observed. In some of these anmals pale yellow liver, white foci on the liver or small spleen were observed. In one of the early died animals an aqueous bloody content in the small intestine, in another oedema of the lungs were observed. Shock due to severe gastrointestinal irritation is assumed to be the cause of death. Liver changes indicate a hepatotoxic effect. Lung oedema is attributed to agonal circulatory breakdown. Small spleen may be caused by haemodynamic disorder or blood loss after intestinal irritation. Chromodacryorrhoeais regarded as a unspecific sign of reduced well being.
- Other findings:
- At terminal necropsy of the surviving animals no changes were noted. All animals were normal.
Any other information on results incl. tables
The LD50 (oral) calculated for both sexes combined was determined to be 80mg/kg bw in mice. The confidence limits (95%) are 71 and 89 mg/kg bw. No pronounced differences in the LD50 values between males (75 mg/kg bw) and females (84 mg/kg bw) were observed.
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- Under the experimental conditions of the study, the LD50 was determined to be 80 mg/kg bw (71-89 mg/kg bw 95% CI) for both sexes combined
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.